Biodesix, Inc. BDSX
Set alert
21.82 USD -1.43 -6.17%
As of Nov 2, 3:51 PM ET
21.37 Day range 23.31
5.26 52-week range 31.97
- YTD
- +220.89%
- 1 year
- +219.48%
- Open
- 23.31
- Prev close
- 23.26
- Mkt cap
- 229.43M
- Vol
- 63.73K
- Avg vol
- 104.58K
- EPS
- -3.10
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 21.37
- High
- 23.31
- Forward P/E
- -6.64
- Beta
- 1.21
- Short ratio
- 0.83
- Inst. own
- 42.83%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.43
- 200-d avg
- 1.53
- 1y target
- 3.10
Financial health
Altman Z-Score
-5.47 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
D+1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -1.5×
FY 2018 5y median -2.9× FY 2025
P/S 0.6×
FY 2018 5y median 2.7× FY 2025
P/B -20.8×
FY 2018 5y median 7.3× FY 2025
P/FCF -2.2×
FY 2018 5y median -3.3× FY 2025
EV/EBITDA -4.8×
FY 2018 5y median -4.8× FY 2025
EV/Sales 1.2×
FY 2018 5y median 2.2× FY 2025
FCF Yield -46.1%
FY 2018 5y median -30.4% FY 2025
Profitability
Gross Margin 81.1%
FY 2018 5y median 73.5% FY 2025
Operating Margin -31.4%
FY 2018 5y median -75.1% FY 2025
Net Margin -39.8%
FY 2018 5y median -79.2% FY 2025
ROE 1430.6%
FY 2018 5y median -218.8% FY 2025
ROIC -38.9%
FY 2018 5y median -62.7% FY 2025
ROA -40.3%
FY 2018 5y median -52.6% FY 2025
Growth (YoY)
Revenue 24.1%
FY 2018 FY 2025
Operating Income 19.5%
FY 2018 FY 2025
EPS (diluted) 29.5%
FY 2018 FY 2025
Free Cash Flow 54.4%
FY 2018 FY 2025
Financial Health
Current Ratio 1.9×
FY 2018 5y median 1.9× FY 2025
Quick Ratio 1.9×
FY 2018 5y median 1.9× FY 2025
Debt / Equity -29.6×
FY 2018 5y median 1.5× FY 2025
Net Debt / EBITDA -2.5×
FY 2018 5y median -0.9× FY 2025
Interest Coverage -3.6×
FY 2018 5y median -4.3× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31